MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0007422
D.K. Biopharma Private Limited - pharma in Ambernath, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.14 Cr
▲ 13% YoY
Net loss · FY 2025
₹4.66 Cr
Net margin -57.2%
EBITDA · FY 2025
₹2.31 Cr
EBITDA margin 28.4%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Satisfied charges
₹36.01 Cr
No open charges
Company age
8 yrs
Est. 2018
Employees · EPFO
51
Provident fund records
About D.K. Biopharma Private Limited
Data last updated:
D.K. Biopharma Private Limited is a private limited company based in Ambernath, Maharashtra, India, a subsidiary of D K Pharma Chem Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36100MH2018PTC311589. Its GSTIN is 27AAGCD7625M1Z7 (Maharashtra).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Rakesh Kasturilal Bakshi and Alka Rakesh Bakshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ambernath, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.14 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net loss of ₹4.66 Cr (net margin -57.2%) and EBITDA of ₹2.31 Cr (EBITDA margin 28.4%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 1% over five years.
The company has about 51 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: DK Biopharma. As per MCA filings, the company has satisfied charges of ₹36.01 Cr on record.
D.K. Biopharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0007422). For more details, the company can be reached via its website dkbiopharma.com.
Company details
CIN U36100MH2018PTC311589
Registration Number 311589
Incorporation Date 05 July 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company D K Pharma Chem Private Limited
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0007422
Key People
Rakesh Kasturilal Bakshi Director Alka Rakesh Bakshi Director Karan Rakesh Bakshi Director Recognitions & Rankings of D.K. Biopharma
Contact details
D.K. Biopharma Private Limited's registered office is in Ambernath, Maharashtra. Its website is dkbiopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 15 16 21/12 & 21/13 MIDC Additional Industrial Estate Mori, Vali, Ambernath, Maharashtra, India – 421501
- IndustryPharma, Drug Formulation & Development
To see the full contact details of D.K. Biopharma Private Limited, buy the company report.
Comprehensive company report
D.K. Biopharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
D.K. Biopharma operates one associated brand: DK Biopharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes as a CDMO focused on manufacturing high-quality recombinant proteins. | dkbiopharma.com |
Business activity
The main business activity of D.K. Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of D.K. Biopharma Private Limited, buy the company report.
Financials of D.K. Biopharma Private Limited
FY 2024 filings availableD.K. Biopharma Private Limited reported revenue of ₹8.14 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹8.14 Cr ▲ 13%
Net loss · FY 2025
₹4.66 Cr margin -57.2%
EBITDA · FY 2025
₹2.31 Cr margin 28.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 14%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▲ 470%
3 years · compounded
▼ 14%
5 years · compounded
▲ 29%
Revenue rose 13% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 470% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.4% | ||||
| Net Profit Margin | -57.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of D.K. Biopharma Private Limited, buy the company report.
Board of directors of D.K. Biopharma Private Limited
D.K. Biopharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kasturilal Bakshi Also directs: Sagitta Private Limited, D.K. Pharma Tech Private Limited, D K Pharma Chem Private Limited and 1 more | Director | 05 Jul 2018 | 8 Years 3 Months | Current |
| Alka Rakesh Bakshi | Director | 05 Jul 2018 | 8 Years 3 Months | Current |
| Karan Rakesh Bakshi Also directs: Sagitta Private Limited, D.K. Pharma Tech Private Limited, D K Pharma Chem Private Limited and 1 more | Director | 04 Oct 2018 | 8 Years 0 Months | Current |
| Ajit Hari Behere Also directs: D K Pharma Chem Private Limited | Director | 25 Nov 2019 | 6 Years 11 Months | Current |
Auditor
D.K. Biopharma Private Limited is audited by P.G. Bhagwat LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.G. Bhagwat LLP | FY 2023 | 101118W |
Shareholding
The shareholding of D.K. Biopharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of D.K. Biopharma Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹36.01 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jul 2019 | 100287533 | Others | ₹2 Cr | Satisfied | |
| 26 Jun 2019 | 100276529 | Others | ₹11.01 Cr | Satisfied | |
| 26 Jun 2019 | 100276623 | Others | ₹1.5 Cr | Satisfied | |
| 28 Apr 2019 | 100295605 | Others | ₹21.5 Cr | Satisfied |
To see the full charge records of D.K. Biopharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving D.K. Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for D.K. Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
D.K. Biopharma Private Limited has a workforce of 51 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
51
Active EPFO establishments
1
Employee growth
-10.53%
GST
D.K. Biopharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD7625M1Z7 | Maharashtra | Active | 23 Aug 2018 |
To see the full GST registrations and return filing status of D.K. Biopharma Private Limited, buy the company report.
Recent activity
D.K. Biopharma Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Ajit Hari Behere ceased to be Additional Director on 31 Dec 2020.
AGM
D.K. Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
D.K. Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 03 Jul 2019 via Charge ID 100287533 with Others was fully satisfied on 04 Jan 2024.
Charges
A charge registered on 26 Jun 2019 via Charge ID 100276623 with Others was fully satisfied on 04 Jan 2024.
Charges
A charge registered on 26 Jun 2019 via Charge ID 100276529 with Others was fully satisfied on 26 Dec 2023.
Charges
A charge with Others of Rs. 1,100.59 Lakh registered on 26 Jun 2019 with Charge ID 100276529 was modified on 06 Apr 2023.
Ceased
Ajit Hari Behere ceased to be Additional Director.
Appointed
Ajit Hari Behere was appointed as Director.
Charges
A charge registered on 28 Apr 2019 via Charge ID 100295605 with Others was fully satisfied on 15 Nov 2019.
Ceased
Ashish Joseph ceased to be Director.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100287533 was registered on 03 Jul 2019.
Charges
A charge with Others amounted to Rs. 150.00 Lakh with Charge ID 100276623 was registered on 26 Jun 2019.
6 earlier events are in the company report.
Frequently asked questions
D.K. Biopharma is an active private limited company based in Ambernath, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 July 2018 (8+ years old) and is registered under CIN U36100MH2018PTC311589.
D.K. Biopharma has 4 current directors:
- Rakesh Kasturilal Bakshi - Director
- Alka Rakesh Bakshi - Director
- Karan Rakesh Bakshi - Director
- Ajit Hari Behere - Director
The latest financial statements of D.K. Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of D.K. Biopharma is 27AAGCD7625M1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of D.K. Biopharma is U36100MH2018PTC311589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
D.K. Biopharma was incorporated on 05 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Ajit Hari Behere ceased to be Additional Director on 31 Dec 2020. Ajit Hari Behere was appointed as Director on 25 Nov 2019. Ashish Joseph ceased to be Director on 16 Sep 2019. D.K. Biopharma has 6 board changes on record in total.
Yes, D.K. Biopharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0007422).
D.K. Biopharma can be reached through the website dkbiopharma.com. Its registered office is in Ambernath, Maharashtra, India.
The registered office of D.K. Biopharma is at Plot No. 15 16 2112 & 2113 MIDC Additional Industrial Estate Mori, Vali, Ambernath, Maharashtra, India – 421501.